Bioforce AG, Switzerland acquired the remaining shares in joint venture Bioforce Denmark A/S, Denmark
Zurich – CFI Switzerland is pleased to announce that they supported Bioforce AG, Switzerland in the acquisition of the shares it did not already own in the joint venture with Bioforce Denmark A/S, Denmark. Prior to closing the transaction, Bioforce AG had a minority interest in Bioforce Denmark A/S.
Bioforce AG develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution. Besides its products, the philosophy of Bioforce is to focus on comprehensive and well-founded information on health topics. Bioforce has 350 employees and generates sales of approx. CHF 110 m.
Bioforce Denmark A/S is the exclusive distributor of Bioforce products in Denmark. The company is run by the founder and owner.
The parties agreed not to disclose further transaction details.
The transaction closed on 1 January 2019.
Healthcare & Life Sciences
acquired the shares it did not already own in its Danish distributor
Transaction details
Bioforce AG (Switzerland), which develops and produces phytopharmaceuticals, nutraceuticals and food supplements, acquired the shares it did not already own in the joint venture with Bioforce Denmark A/S (Denmark), which is the exclusive distributor of Bioforce products
This transaction was advised by:
Our latest transactions
Business Services
has acquired
from
Transaction details
Milon Group has acquired promotional marketing specialist Mediapost España, subsidiary of French group Mediaposte SAS
Automotive
has sold its Precision Turning division to
Transaction details
French industrial Walor Group is selling Walor Precision Turning to Reed Capital
